CORR Insights®: Can Periprosthetic Joint Infection of Tumor Prostheses Be Controlled With Debridement, Antibiotics, and Implant Retention?
作者信息
Allison Daniel C
机构信息
Assistant Professor, Department of Orthopaedic Surgery, University of Southern California and Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Department of Pediatric Orthopaedics, Children's Hospital of Los Angeles, Los Angeles, CA, USA.
出版信息
Clin Orthop Relat Res. 2025 Jan 1;483(1):59-61. doi: 10.1097/CORR.0000000000003236. Epub 2024 Aug 27.
Abstract
摘要
相似文献
1
CORR Insights®: Can Periprosthetic Joint Infection of Tumor Prostheses Be Controlled With Debridement, Antibiotics, and Implant Retention?
Clin Orthop Relat Res. 2025 Jan 1;483(1):59-61. doi: 10.1097/CORR.0000000000003236. Epub 2024 Aug 27.
2
Can Periprosthetic Joint Infection of Tumor Prostheses Be Controlled With Debridement, Antibiotics, and Implant Retention?
Clin Orthop Relat Res. 2025 Jan 1;483(1):49-58. doi: 10.1097/CORR.0000000000003184. Epub 2024 Jul 8.
3
What Is the Incidence of and Outcomes After Debridement, Antibiotics, and Implant Retention (DAIR) for the Treatment of Periprosthetic Joint Infections in the AJRR Population?
Clin Orthop Relat Res. 2024 Nov 1;482(11):2042-2051. doi: 10.1097/CORR.0000000000003138. Epub 2024 Aug 19.
4
Efficacy of Debridement, Antibiotics, and Implant Retention for Periprosthetic Joint Infections Following Hip and Knee Arthroplasty: A Retrospective Cohort Study.
Cureus. 2025 May 21;17(5):e84591. doi: 10.7759/cureus.84591. eCollection 2025 May.
5
Dislocation Rate in Patients Undergoing Debridement, Antibiotics, and Irrigation With Implant Retention for Acute Periprosthetic Hip Infection.
J Arthroplasty. 2025 Jun 3. doi: 10.1016/j.arth.2025.05.097.
6
Debridement, antibiotics, and implant retention (DAIR) for the early prosthetic joint infection of total knee and hip arthroplasties: a systematic review.
J ISAKOS. 2024 Feb;9(1):62-70. doi: 10.1016/j.jisako.2023.09.003. Epub 2023 Sep 13.
7
Is debridement really the best we can do for periprosthetic joint infections following total ankle replacements? A systematic review and meta-analysis.
Foot Ankle Surg. 2022 Aug;28(6):697-708. doi: 10.1016/j.fas.2021.10.008. Epub 2021 Oct 12.
8
Efficacy of the preformulated irrigation solution Bactisure® in acute periprosthetic joint infection debridement surgery: study protocol for a randomized controlled trial.
Trials. 2024 Nov 16;25(1):775. doi: 10.1186/s13063-024-08637-1.
9
Timing From Admission to Debridement, Antibiotics, and Implant Retention Affects Treatment Success in Total Knee Arthroplasty Periprosthetic Joint Infection.
J Arthroplasty. 2025 Jun 19. doi: 10.1016/j.arth.2025.06.042.
10
CORR Insights®: Lower Success Rate of Débridement and Implant Retention in Late Acute versus Early Acute Periprosthetic Joint Infection Caused by Staphylococcus spp. Results from a Matched Cohort Study.
Clin Orthop Relat Res. 2020 Jun;478(6):1356-1358. doi: 10.1097/CORR.0000000000001283.
本文引用的文献
1
Can Periprosthetic Joint Infection of Tumor Prostheses Be Controlled With Debridement, Antibiotics, and Implant Retention?
Clin Orthop Relat Res. 2025 Jan 1;483(1):49-58. doi: 10.1097/CORR.0000000000003184. Epub 2024 Jul 8.
2
Surgical Site Infection in Patients Managed with an Endoprosthesis for the Treatment of Cancer: Evaluation of Patient, Disease, and Index Surgical Factors.
J Bone Joint Surg Am. 2023 Jul 19;105(Suppl 1):87-96. doi: 10.2106/JBJS.22.01376.
3
Surgical Duration Is Independently Associated with an Increased Risk of Surgical Site Infection and May Not Be Mitigated by Prolonged Antibiotics: A Secondary Analysis of the PARITY Trial of Infection After Lower-Extremity Endoprosthetic Reconstruction for Bone Tumors.
J Bone Joint Surg Am. 2023 Jul 19;105(Suppl 1):79-86. doi: 10.2106/JBJS.23.00056.
4
Infections of Tumor Prostheses: An Updated Review on Risk Factors, Microbiology, Diagnosis, and Treatment Strategies.
Biology (Basel). 2023 Feb 15;12(2):314. doi: 10.3390/biology12020314.
5
Comparison of Prophylactic Intravenous Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors: A Randomized Clinical Trial.
JAMA Oncol. 2022 Mar 1;8(3):345-353. doi: 10.1001/jamaoncol.2021.6628.
6
Prophylactic Antibiotic Regimens In Tumor Surgery (PARITY): a multi-center randomized controlled study comparing alternative antibiotic regimens in patients undergoing tumor resections with endoprosthetic replacements-a statistical analysis plan.
Trials. 2021 Mar 22;22(1):223. doi: 10.1186/s13063-021-05147-2.
7
Silver-coated megaprosthesis in prevention and treatment of peri-prosthetic infections: a systematic review and meta-analysis about efficacy and toxicity in primary and revision surgery.
Eur J Orthop Surg Traumatol. 2021 Feb;31(2):201-220. doi: 10.1007/s00590-020-02779-z. Epub 2020 Sep 5.
8
Silver-coated (Agluna®) tumour prostheses can be a protective factor against infection in high risk failure patients.
Eur J Surg Oncol. 2019 Apr;45(4):704-710. doi: 10.1016/j.ejso.2018.12.009. Epub 2018 Dec 14.
9
Silver-coated megaprostheses in the proximal femur in patients with sarcoma.
Eur J Orthop Surg Traumatol. 2019 Jan;29(1):79-85. doi: 10.1007/s00590-018-2270-3. Epub 2018 Jun 20.
10
Silver-Coated Megaprosthesis of the Proximal Tibia in Patients With Sarcoma.
J Arthroplasty. 2017 Jul;32(7):2208-2213. doi: 10.1016/j.arth.2017.02.054. Epub 2017 Mar 1.
Zotero 插件